“Obesity is the number-one health problem in the United States because it negatively affects our population’s health more than any other condition,” said Kaiser Permanente Washington Health Research Institute Senior Investigator David Arterburn, MD, MPH. Kaiser Permanente Washington researchers are doing practical research to learn how doctors, patients, families, employers, and policymakers can best work together to prevent and treat obesity.
“We’re focusing on three ways to halt the obesity epidemic,” said Senior Investigator Dori Rosenberg, PhD, MPH. “We’re helping to change obesity-promoting environments, bringing evidence-based prevention and treatment programs into health care systems, and helping people develop lifelong healthy diet and activity habits.”
Kaiser Permanente Washington obesity research areas include:
“Obesity is caused by many factors, so at Kaiser Permanente Washington, we’re working on many levels,” said Paula Lozano, MD, MPH, a senior investigator and Kaiser Permanente Washington’s assistant medical director for preventive care. “We’re improving health care to help people who are obese now. But since obesity is a societal problem, we’re also studying how to change our homes and workplaces and neighborhoods to create more healthy environments.”
Maciejewski ML, Smith VA, Livingston EH, Kavee AL, Kahwati LC, Henderson WG, Arterburn DE. Health care utilization and expenditure changes associated with bariatric surgery. Med Care. 2010;48(11):989-98. PubMed
Simon GE, Rohde P, Ludman EJ, Jeffery RW, Linde JA, Operskalski BH, Arterburn D. Association between change in depression and change in weight among women enrolled in weight loss treatment. Gen Hosp Psychiatry. 2010;32(6):583-9. Epub 2010 Oct 27. PubMed
Simon GE, Rohde P, Ludman EJ, Jeffery RW, Linde JA, Operskalski BH, Arterburn D, Finch EA. Is success in weight loss treatment contagious (do attendance and outcomes cluster within treatment groups)? Obes Res Clin Pract. 2010;4(4):283-291. PubMed
Wernli KJ, Newcomb PA, Wang Y, Makar KW, Shadman M, Chia VM, Burnett-Hartman A, Wurscher MA, Zheng Y, Mandelson MT. Body size, IGF and growth hormone polymorphisms, and colorectal adenomas and hyperplastic polyps. Growth Horm IGF Res. 2010;20(4):305-9. Epub 2010 May 26. PubMed
Maciejewski ML, Livingston EH, Kahwati LC, Henderson WG, Kavee AL, Arterburn DE. Discontinuation of diabetes and lipid-lowering medications after bariatric surgery at Veterans Affairs medical centers. Surg Obes Relat Dis. 2010;6(6):601-7. Epub 2010 Jul 29. PubMed
David E. Arterburn, MD, MPHSenior Investigator |
Paula Lozano, MD, MPHSenior Investigator; Director, ACT Center |
Allen Cheadle, PhDSenior Investigator, KPWHRI; Senior Research Associate, CCHE |
Dori E. Rosenberg, PhD, MPHSenior Investigator |
Gregory E. Simon, MD, MPHSenior Investigator |
Andrea J. Cook, PhDSenior Biostatistics Investigator |
Beverly B. Green, MD, MPHSenior Investigator |
Maricela Cruz, PhDAssistant Biostatistics Investigator |
Mikael Anne Greenwood-Hickman, MPHCollaborative Scientist |
Laurel Hansell, MA, MPHCollaborative Scientist |
Nicole M. Gatto, PhD, MPHPrincipal Collaborative Scientist |